Glucotrack (GCTK) Gains from Investment Securities (2016 - 2018)
Historic Gains from Investment Securities for Glucotrack (GCTK) over the last 5 years, with Q4 2018 value amounting to $399892.0.
- Glucotrack's Gains from Investment Securities fell 6616.17% to $399892.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $148102.0, marking a year-over-year decrease of 8368.99%. This contributed to the annual value of -$1000.0 for FY2022, which is 9761.9% up from last year.
- According to the latest figures from Q4 2018, Glucotrack's Gains from Investment Securities is $399892.0, which was down 6616.17% from -$91762.0 recorded in Q3 2018.
- Over the past 5 years, Glucotrack's Gains from Investment Securities peaked at $1.2 million during Q4 2017, and registered a low of -$6.1 million during Q2 2014.
- Moreover, its 5-year median value for Gains from Investment Securities was -$71858.5 (2015), whereas its average is -$324766.8.
- As far as peak fluctuations go, Glucotrack's Gains from Investment Securities skyrocketed by 109685.58% in 2016, and later tumbled by 14201.94% in 2017.
- Over the past 5 years, Glucotrack's Gains from Investment Securities (Quarter) stood at -$50635.0 in 2014, then skyrocketed by 45.02% to -$27839.0 in 2015, then skyrocketed by 1014.5% to $254587.0 in 2016, then surged by 364.19% to $1.2 million in 2017, then tumbled by 66.16% to $399892.0 in 2018.
- Its Gains from Investment Securities was $399892.0 in Q4 2018, compared to -$91762.0 in Q3 2018 and -$82081.0 in Q2 2018.